One world, many angles.
The Section
The appointments, bills and small print of staying well, explained before you're in the waiting room.
Section Lead · promoted for you
healthcare for everyone 29 Jul
Two company trials hit their marks and one independent trial missed, but all three measured psilocybin against people who knew they were the control group.
0healthcare for everyone
Two careful studies found microplastics in human brains and in artery plaque and linked both to harm, yet neither shows the plastic did the harm.
0healthcare for everyone
Three oral weight-loss candidates posted trial data this year, but the number that matters is not on the scale, it is on the loading dock.
0This week · in Healthcare
healthcare for everyone 29 Jul
An AI that reads your blood is billed as a 15-year heart warning, so I opened the study's own data to size what it adds.
0healthcare for everyone 24 Jul
A Yale analysis traces four years of empty pharmacy shelves to a steep drop in raw amphetamine imports, not the adults and children everyone keeps blaming.
0healthcare for everyone 17 Jul
A vaccine older adults already qualify for keeps turning up next to lower dementia rates, across countries and methods, but no trial has closed the case.
0healthcare for everyone 16 Jul
Colorectal cancer is now the leading cancer killer of people under 50, and the honest answer to why is that nobody fully knows yet.
0healthcare for everyone 16 Jul
Three semaglutide trials and a statistical emulation link the drug to fewer heart and kidney events, and new data say weight loss is not why.
1healthcare for everyone 16 Jul
A landmark Cochrane review says amyloid-clearing drugs barely help, but the two currently licensed on their own show a small, real benefit with a real cost attached.
0healthcare for women 16 Jul
The FDA removed its black-box warning on menopause hormone therapy in February, admitting the fear it built in 2002 rested on the wrong women.
0More in Healthcare
